Stockreport

Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026

Daxor Corporation - Closed End Fund  (DXR) 
NASDAQ:AMEX Investor Relations: daxor.com/investors
PDF OAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new c [Read more]